Blackhawk Capital Partners’s Bausch Health BHC Stock Holding History

Blackhawk Capital Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-86,742	Closed	-$725K	–	67
2022 Q2	$725K	Buy	+86,742	New	+$1.21M	0.57%	57
2018 Q3	–	Sell	-1,000	Closed	-$16K	–	97
2018 Q2	$16K	Hold	1,000	–	–	0.02%	237
2018 Q1	$16K	Buy	+1,000	New	+$18.6K	0.01%	254

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Blackhawk Capital Partners's BHC Position: Q3 2022 in Review

Blackhawk Capital Partners sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 86,742 shares — an estimated $725K sold.

Blackhawk Capital Partners first reported a position in BHC in Q1 2018 and held it in 3 quarters. The position peaked at $725K in Q2 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

Blackhawk Capital Partners reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
Blackhawk Capital Partners sold 86,742 Bausch Health shares in Q3 2022, an estimated $725K.
Blackhawk Capital Partners first reported a position in Bausch Health in Q1 2018 and held it in 3 quarters.
Blackhawk Capital Partners's Bausch Health position peaked at $725K in Q2 2022.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Blackhawk Capital Partners's 13F filing for Q3 2022, filed 9 Nov 2022.